Literature DB >> 16702314

Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells.

Gabriel K Harris1, Yong Qian, Stephen S Leonard, Deborah C Sbarra, Xianglin Shi.   

Abstract

Inflammation and oxidative stress are associated with cancer, atherosclerosis, and other chronic diseases. Dietary flavonoids have been reported to possess antiinflammatory and antioxidant properties, but their mechanisms of action and structure-activity relations have not been fully investigated. We hypothesized that differences in antioxidant activity between the structurally similar flavones, luteolin and chrysin (differing only in B-ring hydroxylation patterns), would differentially affect inflammation-associated Cox-2 expression and PGE2 formation. Pretreatment of RAW 264.7 macrophage-like cells with 25, 50, or 100 micromol/L concentrations of luteolin inhibited lipopolysaccharide (LPS)-induced Cox-2 protein expression (P < 0.0001). Chrysin pretreatment did not reduce LPS-induced Cox-2 protein expression at any level tested. Conversely, both luteolin and chrysin completely suppressed LPS-induced PGE2 formation (P < 0.001). Luteolin, but not chrysin, inhibited xanthine/xanthine oxidase-generated superoxide formation at 100 micromol/L in a cell-free system (P < 0.001). Although both luteolin and chrysin reduced LPS-induced hydroxyl radical formation relative to the positive control (P < 0.001), luteolin was superior to chrysin (P = 0.003). In summary, luteolin and chrysin suppressed PGE2 formation equally well, despite differential effects on Cox-2 protein expression and on superoxide and hydroxyl radical scavenging. These data indicate that flavones may display similar antiinflammatory activity via different mechanisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702314     DOI: 10.1093/jn/136.6.1517

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  25 in total

1.  Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice.

Authors:  Saebyeol Jang; Ryan N Dilger; Rodney W Johnson
Journal:  J Nutr       Date:  2010-08-04       Impact factor: 4.798

2.  Main constituents of polyphenol complex from seagrasses of the genus Zostera, their antidiabetic properties and mechanisms of action.

Authors:  Olga Nikolaevna Styshova; Alexander Michailovich Popov; Alexander Alekseevish Artyukov; Anna Anatolievna Klimovich
Journal:  Exp Ther Med       Date:  2017-03-10       Impact factor: 2.447

3.  Protective effects of luteolin against lipopolysaccharide-induced acute lung injury involves inhibition of MEK/ERK and PI3K/Akt pathways in neutrophils.

Authors:  Jen-pei Lee; Yi-ching Li; Hung-yi Chen; Ruey-hseng Lin; Shiang-suo Huang; Hui-ling Chen; Pai-chuan Kuan; Mao-fang Liao; Chun-jung Chen; Yu-hsiang Kuan
Journal:  Acta Pharmacol Sin       Date:  2010-06-21       Impact factor: 6.150

4.  Luteolin inhibits Cr(VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways.

Authors:  Poyil Pratheeshkumar; Young-Ok Son; Sasidharan Padmaja Divya; Ram Vinod Roy; John Andrew Hitron; Lei Wang; Donghern Kim; Jin Dai; Padmaja Asha; Zhuo Zhang; Yitao Wang; Xianglin Shi
Journal:  Toxicol Appl Pharmacol       Date:  2014-10-23       Impact factor: 4.219

5.  Improving water dispersibility and bioavailability of luteolin using microemulsion system.

Authors:  Ayaka Miyashita; Junya Ito; Isabella Supardi Parida; Naoki Syoji; Tomoyuki Fujii; Hidehiro Takahashi; Kiyotaka Nakagawa
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

Review 6.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

7.  Luteolin reduces obesity-associated insulin resistance in mice by activating AMPKα1 signalling in adipose tissue macrophages.

Authors:  Lei Zhang; Yi-Jing Han; Xian Zhang; Xin Wang; Bin Bao; Wei Qu; Jian Liu
Journal:  Diabetologia       Date:  2016-07-04       Impact factor: 10.122

8.  Luteolin Suppresses Inflammatory Mediator Expression by Blocking the Akt/NFκB Pathway in Acute Lung Injury Induced by Lipopolysaccharide in Mice.

Authors:  Yi-Ching Li; Chung-Hsin Yeh; Ming-Ling Yang; Yu-Hsiang Kuan
Journal:  Evid Based Complement Alternat Med       Date:  2011-11-20       Impact factor: 2.629

9.  Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype.

Authors:  Konstantin Dirscherl; Marcus Karlstetter; Stefanie Ebert; Dominik Kraus; Julia Hlawatsch; Yana Walczak; Christoph Moehle; Rudolf Fuchshofer; Thomas Langmann
Journal:  J Neuroinflammation       Date:  2010-01-14       Impact factor: 8.322

10.  Molecular mechanisms underlying the in vitro anti-inflammatory effects of a flavonoid-rich ethanol extract from chinese propolis (poplar type).

Authors:  Kai Wang; Shun Ping; Shuai Huang; Lin Hu; Hongzhuan Xuan; Cuiping Zhang; Fuliang Hu
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.